Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 131, 108416
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Association between trajectories of buprenorphine treatment and emergency department and in‐patient utilizationAddiction, 2016
- Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and OutcomesJournal of Substance Abuse Treatment, 2015
- Analysis of Buprenorphine/Naloxone Dosing Impact on Treatment Duration, Resource Use and Costs in the Treatment of Opioid-Dependent Adults: A Retrospective Study of US Public and Private Health Care ClaimsPostgraduate Medicine, 2014
- Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent PatientsJournal of Substance Abuse Treatment, 2014
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trialAddiction, 2013
- Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted TreatmentJournal of Addictive Diseases, 2012
- Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid AddictionJournal of Addiction Medicine, 2011
- Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United StatesPain Medicine, 2011
- Economic Costs of Nonmedical Use of Prescription OpioidsThe Clinical Journal of Pain, 2011
- Costs of Opioid Abuse and Misuse Determined From a Medicaid DatabaseJournal of Pain & Palliative Care Pharmacotherapy, 2010